The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of a randomized, open label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC.
 
Ahmed Omar Kaseb
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Bayer Health; Bristol-Myers Squibb; Exelixis; Merck
Consulting or Advisory Role - Bayer Health; Bristol-Myers Squibb; Exelixis; Merck
Research Funding - Adaptimmune (Inst); Bayer/Onyx (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Hengrui Pharmaceutical (Inst); Hengrui Pharmaceutical (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Bristol-Myers Squibb; Exelixis; Merck
 
Hop Sanderson Tran Cao
No Relationships to Disclose
 
Yehia I. Mohamed
No Relationships to Disclose
 
Aliya Qayyum
No Relationships to Disclose
 
Luis M. Vence
No Relationships to Disclose
 
Jorge M. Blando
No Relationships to Disclose
 
Shalini Singh
No Relationships to Disclose
 
Sunyoung S. Lee
No Relationships to Disclose
 
Kanwal Pratap Singh Raghav
Honoraria - Bayer; Eisai
 
Lina Altameemi
No Relationships to Disclose
 
Asif Rashid
No Relationships to Disclose
 
Jean-Nicolas Vauthey
No Relationships to Disclose
 
Kristen Carter
No Relationships to Disclose
 
Ching-Wei David Tzeng
No Relationships to Disclose
 
Yun Shin Chun
No Relationships to Disclose
 
James C. Yao
No Relationships to Disclose
 
Robert A. Wolff
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
 
James Patrick Allison
Stock and Other Ownership Interests - Achelois Oncology; Apricity Health (I); Apricity Therapeutics; BioAtla; BioAtla (I); Codiak Biosciences; Codiak Biosciences (I); Constellation Pharmaceuticals (I); Dragonfly Therapeutics; Forty Seven; Forty Seven (I); Hummingbird; Hummingbird (I); ImaginAb; ImaginAb (I); Jounce Therapeutics; Jounce Therapeutics (I); Lava Therapeutics; Lytix Biopharma; Marker Therapeutics; Neon Therapeutics (I); Oncolytics (I); OPTERA; Polaris; Polaris (I); Tvardi therapeutics
Patents, Royalties, Other Intellectual Property - Inventor of a patent licensed to Merck; Inventor of a patent owned by Memorial Sloan-Kettering Cancer Center and licensed by Jounce Therapeutics
 
Padmanee Sharma
Stock and Other Ownership Interests - Apricity Health; Apricity Health (I); BioAtla; BioAtla (I); Codiak Biosciences; Codiak Biosciences (I); Constellation Pharmaceuticals; Constellation Pharmaceuticals (I); Dragonfly Therapeutics; Forty Seven; Forty Seven (I); Hummingbird; ImaginAb; ImaginAb (I); Jounce Therapeutics; Jounce Therapeutics (I); Lytix Biopharma; Lytix Biopharma (I); Marker Therapeutics; Marker Therapeutics (I); Neon Therapeutics; Neon Therapeutics (I); Oncolytics; Polaris; Polaris (I); Tvardi Therapeutics (I)
Consulting or Advisory Role - Achelois Oncology; Achelois Oncology (I); Apricity Health; Apricity Health (I); BioAtla; BioAtla (I); Bristol-Myers Squibb; Bristol-Myers Squibb (I); Codiak Biosciences; Codiak Biosciences (I); Constellation Pharmaceuticals; Constellation Pharmaceuticals (I); Dragonfly Therapeutics; Dragonfly Therapeutics (I); Forty Seven; Forty Seven (I); Hummingbird; Hummingbird (I); ImaginAb; ImaginAb (I); Jounce Therapeutics; Jounce Therapeutics (I); Lytix Biopharma; Lytix Biopharma (I); Marker Therapeutics; Marker Therapeutics (I); Neon Therapeutics; Neon Therapeutics (I); Oncolytics; Pieris Pharmaceuticals; Polaris; Polaris (I); Tvardi Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Own patent licensed to Jounce; Own patents licensed to BMS, Jounce & Merck (I)